Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice

Aguirre-Bañuelos, 2008, Inorganic arsenic exposure affects pain behavior and inflammatory response in rat, Toxicol. Appl. Pharmacol., 229, 374, 10.1016/j.taap.2008.01.029

Banerjee, 2009, Ascorbic acid combats arsenic-induced oxidative stress in mice liver, Ecotoxicol. Environ. Saf., 72, 639, 10.1016/j.ecoenv.2008.07.005

Benson, 2004, Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity, Hypertension, 43, 993, 10.1161/01.HYP.0000123072.34629.57

Bera, 2010, l-Ascorbate protects rat hepatocytes against sodium arsenite-induced cytotoxicity and oxidative damage, Hum. Exp. Toxicol., 29, 103, 10.1177/0960327109357215

Blessing, 2008, Antiatherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice, Atherosclerosis, 199, 295, 10.1016/j.atherosclerosis.2007.10.037

Bortolami, 2002, Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer, Dig. Liver Dis., 34, 794, 10.1016/S1590-8658(02)80073-1

Cai, 2003, The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases, Trends Pharmacol. Sci., 24, 471, 10.1016/S0165-6147(03)00233-5

Chai, 2007, Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells, Mutagenesis, 22, 403, 10.1093/mutage/gem035

Cheng, 2004, Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2, Mod. Pathol., 17, 1169, 10.1038/modpathol.3800196

Clancy, 1995, Nitric oxide: a novel mediator of inflammation, Proc. Soc. Exp. Biol. Med., 210, 93, 10.3181/00379727-210-43927AA

Das, 2009, Taurine protects rat testes against NaAsO(2)-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways, Toxicol. Lett., 187, 201, 10.1016/j.toxlet.2009.03.001

Dong, 2002, The molecular mechanisms of arsenic-induced cell transformation and apoptosis, Environ. Health Perspect., 110, 757, 10.1289/ehp.02110s5757

Drobná, 2010, Metabolism of arsenic in human liver: the role of membrane transporters, Arch. Toxicol., 84, 3, 10.1007/s00204-009-0499-7

Enjoji, 2008, Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study, Int. J. Mol. Med., 22, 521

Flora, 2009, Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats, Toxicol. Appl. Pharmacol., 240, 236, 10.1016/j.taap.2009.05.013

Ghosh, 2010, Quercetin in vesicular delivery system: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model, Chem. Biol. Interact., 186, 61, 10.1016/j.cbi.2010.03.048

Guo, 2011, Rb1 postconditioning attenuates liver warm ischemia-reperfusion injury through ROS-NO-HIF pathway, Life Sci., 88, 598, 10.1016/j.lfs.2011.01.022

Ha, 2010, Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity, Exp. Anim., 59, 595, 10.1538/expanim.59.595

Halici, 2009, Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?, Eur. J. Pharmacol., 614, 146, 10.1016/j.ejphar.2009.04.042

Hou, 2000, Inductively coupled plasma/optical emission spectrometry, 9468, 10.1002/9780470027318.a5110

Jin, 2007, Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient l-amino acid-defined diet, Biochem. Biophys. Res. Commun., 364, 801, 10.1016/j.bbrc.2007.10.083

Kang, 2006, Metallothionein redox cycle and function, Exp. Biol. Med. (Maywood), 231, 1459, 10.1177/153537020623100903

Kudo, 2009, Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue, Liver Int., 29, 988, 10.1111/j.1478-3231.2009.02006.x

Kuwashiro, 2011, Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation, Cell Tissue Res., 344, 125, 10.1007/s00441-011-1132-7

Li, 2002, NF-kappaB regulation in immune system, Nat. Rev. Immunol., 2, 725, 10.1038/nri910

Liu, 2001, Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity, Proc. Natl. Acad. Sci. U.S.A., 98, 1643, 10.1073/pnas.031482998

Liu, 2011, Effects of telmisartan on nonalcoholic steatohepatitis rat model by activating peroxisome proliferator-activated receptor r, Zhonghua Gan Zang Bing Za Zhi, 19, 614

Majumdar, 2011, Arsenic-induced hepatic mitochondrial toxicity in rats and its amelioration by dietary phosphate, Environ. Toxicol. Pharmacol., 31, 107, 10.1016/j.etap.2010.09.011

Martin, 2004, Evidence that 1,1-dichloroethylene induces apoptotic cell death in murine liver, J. Pharmacol. Exp. Ther., 310, 33, 10.1124/jpet.104.066019

Mazumder, 2005, Effect of chronic intake of arsenic-contaminated water on liver, Toxicol. Appl. Pharmacol., 206, 169, 10.1016/j.taap.2004.08.025

Moreno, 2009, Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver, Am. J. Physiol. Gastrointest. Liver Physiol., 296, G147, 10.1152/ajpgi.00462.2007

Morishima, 2009, Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes, Eur. J. Pharmacol., 609, 105, 10.1016/j.ejphar.2009.03.024

Morris, 1994, New insights into the regulation of inducible nitric oxide synthesis, Am. J. Physiol., 266, E829

Nakamura, 2005, Oxidative DNA injury after experimental intracerebral hemorrhage, Brain Res., 1039, 30, 10.1016/j.brainres.2005.01.036

Pan, 2011, Inhibition of arsenic induced-rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-β/Smad activation, Toxicol. Appl. Pharmacol., 254, 323, 10.1016/j.taap.2011.04.022

Pari, 2011, Protective role of sinapic acid against arsenic-induced toxicity in rats, Chem. Biol. Interact., 194, 40, 10.1016/j.cbi.2011.08.004

Pott, 2001, Pharmacokinetics, metabolism and carcinogenicity of arsenic, Rev. Environ. Contam. Toxicol., 169, 165, 10.1007/978-1-4613-0107-3_3

Rooney, 2007, The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury, Toxicology, 234, 145, 10.1016/j.tox.2007.02.016

Shi, 2004, Oxidative mechanism of arsenic toxicity and carcinogenesis, Mol. Cell. Biochem., 255, 67, 10.1023/B:MCBI.0000007262.26044.e8

Singh, 2010, Adverse health effects due to arsenic exposure: modification by dietary supplementation of jaggery in mice, Toxicol. Appl. Pharmacol., 242, 247, 10.1016/j.taap.2009.10.014

Singh, 2010, Ascorbic acid improves mitochondrial function in liver of arsenic-treated rat, Toxicol. Ind. Health, 26, 265, 10.1177/0748233710365694

Souza-Mello, 2010, Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet, Clin. Sci. (Lond.), 119, 239, 10.1042/CS20100061

Straub, 2008, Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide, J. Clin. Invest., 118, 3980, 10.1172/JCI35092

Takaya, 2006, Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice, Atherosclerosis, 186, 402, 10.1016/j.atherosclerosis.2005.08.009

Takeshita, 2008, Cross talk of tumor necrosis factor-alpha and the renin-angiotensin system in tumor necrosis factor-alpha-induced plasminogen activator inhibitor-1 production from hepatocytes, Eur. J. Pharmacol., 579, 426, 10.1016/j.ejphar.2007.11.016

Toblli, 2008, ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats, Obesity (Silver Spring), 16, 770, 10.1038/oby.2007.114

Tseng, 2004, The potential biological mechanisms of arsenic-induced diabetes mellitus, Toxicol. Appl. Pharmacol., 197, 67, 10.1016/j.taap.2004.02.009

Viebahn, 2010, Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury, J. Hepatol., 53, 500, 10.1016/j.jhep.2010.04.010

Wei, 2008, Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats, J. Hepatol., 49, 417, 10.1016/j.jhep.2008.03.018

Wolf, 2000, Angiotensin II as a mediator of tubulointerstitial injury, Nephrol. Dial. Transplant., 15, 61, 10.1093/ndt/15.suppl_6.61

World Health Organization, 2001. Arsenic in Drinking Water. WHO Fact Sheet No. 210, <http://www.who.int/int-fs/en/fact210.html>.

Xu, 2011, Telmisartan protects against insulin resistance by attenuating inflammatory response in rats, J. Huazhong Univ. Sci. Technol. Med. Sci., 31, 317, 10.1007/s11596-011-0374-7

Yang, 2009, Protective effect of JBP485 on concanavalin A-induced liver injury in mice, J. Pharm. Pharmacol., 61, 767, 10.1211/jpp.61.06.0009

Yu, 2008, Activation of TLR-4 and liver injury via NF-kappa B in rat with acute cholangitis, Hepatobiliary Pancreat. Dis. Int., 7, 185